Core technology across SEERS (spectral imaging for IR surveillance), EXIST (extended image sensing), and PHOOTONICS (hyperspectral imaging for health).
QUEST PHOTONIC DEVICES BV
Dutch SME building hyperspectral and infrared imaging devices, pivoting from surveillance applications toward medical diagnostics for diabetes monitoring.
Their core work
Quest Photonic Devices (trading as Quest Innovations) is a Dutch SME specializing in photonics-based imaging and sensing systems, particularly hyperspectral cameras and infrared detection devices. They develop hardware combining passive photodetectors and active illuminators operating in the near-infrared (NIR) and mid-infrared (mid-IR) spectrum ranges. Their technology has applications ranging from surveillance and security imaging to medical diagnostics, most recently focusing on non-invasive monitoring devices for diabetic foot conditions.
What they specialise in
All four projects involve infrared detection or sensing — from surveillance (SEERS) to health monitoring (PHOOTONICS with NIR/mid-IR sensing).
PHOOTONICS explicitly lists passive photodetectors and active illuminators; EXIST focused on extended image sensing technologies.
PHOOTONICS (2019-2024) applies their imaging expertise to diabetic foot prediction and monitoring — a clear pivot toward health applications.
How they've shifted over time
In the early period (2015-2018), Quest focused on general-purpose infrared imaging and sensing for surveillance and industrial applications through SEERS and EXIST. From 2016 onward, ASTONISH signaled a shift toward health-oriented smart optical imaging. By 2019, PHOOTONICS confirmed a decisive move into medical photonics — applying their core hyperspectral and IR expertise to diabetic foot monitoring, a specific clinical use case with clear commercial potential.
Quest is transitioning from general-purpose infrared imaging toward medtech applications, making them an increasingly relevant partner for health-tech and clinical device projects.
How they like to work
Quest has participated exclusively as a partner, never as a coordinator, across all four H2020 projects — consistent with a specialist technology supplier role. With 57 unique consortium partners across 14 countries, they operate in large ECSEL-type consortia (typically 20+ partners), suggesting they are comfortable contributing specific hardware components within complex multi-partner projects. Their broad partner network indicates openness to new collaborations rather than reliance on a fixed set of allies.
Quest has collaborated with 57 different partners across 14 countries, a wide network built primarily through large ECSEL joint undertaking consortia. This gives them connections across the European photonics and electronics ecosystem.
What sets them apart
Quest occupies a niche at the intersection of photonics hardware manufacturing and application-specific imaging solutions — they don't just research sensors, they build devices. As a Dutch SME with deep infrared and hyperspectral expertise, they can contribute production-ready imaging components that larger partners typically cannot provide in-house. Their recent pivot into medical devices positions them uniquely as a photonics company that bridges the gap between industrial sensing and clinical diagnostics.
Highlights from their portfolio
- PHOOTONICSTheir most recent and second-largest project (EUR 636K), representing a strategic pivot into medical devices for diabetic foot monitoring using their core hyperspectral technology.
- SEERSTheir largest single grant (EUR 743K) and earliest H2020 project, focused on cost-effective infrared spectral imaging for surveillance — the foundation of their imaging expertise.